Screener/Healthcare/Biotechnology

ROIV

Roivant Sciences Ltd.NASDAQ
$26.96-0.96 (-3.44%)
Large CapUnder $50Healthcare
$8.73
$30.33
$26.59
$27.83
EPS (TTM)$-1.17
P/E Ratio—
Dividend Yield—
Market Cap$19.99B
Volume2.35M
Prev Close$27.93
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '26$2.0M-$313.7M$-0.38—-15692.9%
Q2 '26$1.6M-$166.0M$-0.17—-10569.0%
Q1 '26$2.2M-$273.9M$-0.33—-12622.6%
Q4 '25$7.6M-$252.4M$-0.29—-3333.9%
Q4 '24$7.6M-$206.5M$-0.2997.3%-2727.5%
Q3 '25$9.0M$118.1M$0.2314.4%1309.3%
Q2 '25$4.5M-$279.9M$-0.3132.6%-6255.3%
Q1 '25$55.1M$57.5M$0.123.7%104.3%
Get Your Daily Market Recap